🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Low vs moderate-intensity anticoagulation for VV #ECMO 🔍 SAFE-ECMO pilot trial; 3 centers across 🇺🇸 💉 intermittent SC anticoagulant (doses for DVT prophylaxis) vs traditional approach to anticoagulation with continuous, goal-titrated, infusion 🩸major bleedings 8.3% in low vs

🧵1/ People love to quote this stat about U.S. health: “We spend the most but live shorter lives!” It’s true, but blaming scientists for that totally misses the point. The real story is more complicated - and more important.

I've noticed alot of people don’t realize how deeply medical innovation in this country depends on the NIH. From cancer immunotherapy to vaccines to obesity drugs like GLP-1s: it all starts with public funding. Here's a quick primer on the treatment pipeline in case helpful.

We invite you to participate in a focus group to share your valuable insights on implementing these steps to improve in-hospital cardiac arrest outcomes and care quality by clicking the link. 👇 🔗 lnkd.in/evVcXvpv #IHCA #ILCOR #science #resuscitation

Just out: the ILCOR systematic review on Oxygen and carbon dioxide targets after cardiac arrest sciencedirect.com/science/articl… ILCOR Aus-ROC

A devastating loss for the global intensive care community. It was a true honor meeting Prof Bellomo in person at this year’s ANZICS Clinical Trials Group Noosa meeting after reading his practice and paradigm-changing work for many years.

What is the impact of #LV #unloading during #ECPR? Target trial emulation using #ELSO registry: 🏥 300 centres, 621 matched pairs ❌ LV unloading NOT a/w survival benefits 💘 More CNS, CVS, and metabolic complications, and longer #ECMO durations! link.springer.com/article/10.118…

In critically ill patients, neither dexmedetomidine nor clonidine was superior to propofol in reducing time to successful extubation. #ATS2025 ja.ma/3SFgz54

Finally some evidence to support a concept we’ve taught for years. Save the right IJ for when it’s absolutely necessary (eg, dialysis, ECMO). Kudos to the authors. sciencedirect.com/science/articl…

Don’t miss your chance to apply for the 3CPR Council Mid-Career award 🏆 If you’re a mid-career resuscitation scientist- this is for you! #ReSS25 Deadline: June 6!!!! Present your work in Nola at ReSS25 American Heart Association AHAMeetings professional.heart.org/en/professiona….

Are you an early career resuscitation scientist? Do you want to present your work to leaders in resuscitation science? Don’t miss the Max Harry Weill Early Career Competition at #ReSS25 Deadline: June 6 3CPR Council American Heart Association AHAMeetings professional.heart.org/en/professiona…

The TARGET Protein trial explained by the trialists #CCR25 #TARGETproteintrial A/Prof Lee-anne Chapple Matt Summers Adam Matthew Deane ANZICS Clinical Trials Group

TTM Biomarker study explained by Niklas Nielsen & Marion Moseby-Knappe #CCR25

UK-ROX with Dan Martin and Paul Mouncey is about to give us their results! Join the conversation online - send us your questions and we'll ask the investigators. #CCR25

Conservative oxygen therapy with a target SpO2 of 90% did not reduce 90-day all-cause mortality compared to usual oxygen therapy in mechanically ventilated adult patients. #CCR25 Critical Care Reviews ja.ma/43Ry4Ep

Presented at #CCR25: In a cluster-randomized, crossover trial, hospital-wide use of lactated Ringer’s solution as compared with normal saline did not alter the incidence of death or hospital readmission within 90 days. Full trial results: nej.md/45SaEBs

I’m not on here as much as I once was, but if you want a great follow, I highly recommend my colleague and friend Ann L. Jennerich, MD MS ATSF, who is bringing the truth lately and providing balanced perspective on the latest in medicine and science.

⭐️Please join us in congratulating our honorees, the ILCOR “Giants” for 2025: Dianne Atkins, Judith Finn, Robert “Tino” Greif, Rudy Koster, and Robert Neumar, who will join the elite group of ILCOR "Giants" established since 1985. 👉ilcor.org/about/ilcor-gi…. #ILCOR #ILCORGiants

📣 We are very pleased to announce that the 2025 #ImpactFactor of #Resuscitation is 4.6! Thanks to our editors, reviewers, authors, and readers who made this possible!

📣 We are very pleased to announce that the 2025 #ImpactFactor of #ResuscitationPlus is 2.4! Thanks to our editors, reviewers, authors, and readers who made this possible!